Trial Profile
A retrospective study of Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir who discontinued therapy after seroconversion and consolidation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 04 Dec 2017 New trial record